Dr Emma Davies (AZ) receives 3Rs prize for work on ex vivo tumour slices
Posted on 2017-08-07 10:34:17 EEST.
The Innovative Medicines Initiative project PREDECT (www.predect.eu) team member Dr Emma Davies from AstraZeneca (AZ), working with Drs Simon Barry from AZ and Shannon Burke from Medimmune, receives the 3Rs prize for work on the continuing development of ex vivo tumour slices.
Precision cut 200-300 micron slices capture, ex vivo, the in vivo complexity and heterogeneity of tumours and reduce animal use (3Rs) (Davies et al Sci. Rep. 5, 17187; doi: 10.1038/srep17187 (2015)) and are an important in vitro advanced platform for drug discovery.
Shown are, from left, Pascal Soriot (CEO of AZ), Bahija Jallal (Executive Vice-President of Medimmune), Dr Emma Davies, Shannon Burke and Mene Pangalos (Head of Innovative Medicines Unit at AZ).